Review of screenshots for electronic implementation of EORTC instruments Dagmara Kulis 1 , Anas Simon 1 , Jens Lehmann 2 1 EORTC, Brussels, Belgium, 2 Medical University of Innsbruck, Innsbruck, Austria Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2038 Aims With reducing timelines to start of trials being a priority for sponsors, migration of patient-reported outcome (PRO) measures onto electronic platforms as ePROs remains a process perceived as excessively long, especially due to the copyright holder review (CHR) of the screenshots
Semaglutide Semaglutide is a GLP-1 receptor agonist, a synthetic analog of glucagon-like peptide-1, an intestinal hormone released after eating
Beyond appetite control, it boosts calorie-burning by stimulating insulin release helping your body use stored fat for energy
Read more here if youre curious about other options: Is there an alternative to Ozempic or Wegovy The Bottom Line Semaglutide tiredness does happen, but it is only temporary
If youve struggled to lose weight in the past or are looking for a more effective solution, GLP-1 medications could be the solution youve been waiting for